Cor Vasa 2019, 61(1):48-55 | DOI: 10.1016/j.crvasa.2018.06.006
Foam cell formation and cholesterol trafficking and metabolism disturbances in atherosclerosis
- a Laboratory of Gene Therapy, Biocad Biotechnology Company, 198515 Saint-Petersburg, Russia
- b Diabetes Research Center, Traditional Chinese Medicine School, Beijing University of Chinese Medicine, 100029 Beijing, China
- c Federal Scientific Clinical Center for Resuscitation and Rehabilitation, 109240 Moscow, Russia
- d Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia
- e Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
Foam cells are typical components of atherosclerotic plaques, where they actively participate in the intracel- lular cholesterol accumulation. Onset and further progression of atherosclerosis is tightly associated with foam cell formation. These cells can originate both from the circulating monocytes/macrophages and from the resident smooth muscular cells migrating to the growing lesion. Classically activated pro-inflammatory M1 macrophages play an important role in atherogenesis, while M2 macrophages have a protective role in plaque stabilization. Molecular mechanisms for VSMC transformation towards foam cells remains to be studied in detail. Lipid droplets filling the foam cells are generated from metabolized modified low-density lipoproteins (LDL). LDL serves as the main source or lipids, which penetrate the endothelium both via LDL-receptor-dependent and alternative ALK-1-regulated pathways. Under pathologic conditions, LDL can undergo modification, such as sialylation, oxidation, glycation or carbamylation, leading to its excessive uptake by macrophages infiltrating the subendothelial space. Modified LDL is recognized mainly by scavenger receptors, such as SR-A1, CD36, LOX-1, CD68, those expression is low under physiological conditions and can be upregulated via JNK, Wnt and NF-κB signaling. In foam cells LDL is digested to fatty acids and free cholesterol. Cholesterol can be esterified and further hydrolyzed for efflux to poorly lipidated ApoA-I or mature HDL. In this review, we discuss the basic concepts in foam cell formation established so far, as well as different aspects of cholesterol uptake, metabolism and efflux disturbances in atherosclerosis.
Keywords: Atherosclerosis, Cholesterol accumulation, Foam cells, LDL
Received: May 7, 2018; Revised: June 24, 2018; Accepted: June 26, 2018; Published: March 21, 2019 Show citation
References
- Sobenin IA, Chistiakov DA, Bobryshev YV, Orekhov AN. Blood atherogenicity as a target for anti-atherosclerotic therapy. Curr Pharm Des 2013;19:5954-5962.
Go to original source...
- Alipov V, Sukhorukov V, Karagodin V, et al. Chemical composition of circulating native and desialylated low density lipoprotein: what is the difference? Vessel Plus 2017;1:107-115.
Go to original source...
- Rossman C. Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells. PLoS One. 2018;13(1):e0191477.
Go to original source...
Go to PubMed...
- Sobenin IA, Salonen JT, Zhelankin AV, et al. Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value. Biomed Res Int 2014;2014:205697.
Go to original source...
Go to PubMed...
- Mundi S. Endothelial permeability, LDL deposition, and cardiovascular risk factors - a review. Cardiovasc Res 2018;114:35-52.
Go to original source...
Go to PubMed...
- Lehti S. Extracellular Lipids Accumulate in Human Carotid Arteries as Distinct Three-Dimensional Structures and Have Proinflammatory Properties. Am J Pathol 2018;188:525-538.
Go to original source...
Go to PubMed...
- Sievi I. Regulation and function of endothelial glycocalyx layer in vascular diseases. Vascul Pharmacol 2018;100:26-33.
Go to original source...
Go to PubMed...
- Mytra R. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target. Curr Atheroscler Rep 2017;19:63.
Go to original source...
Go to PubMed...
- Bai X. Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop. Oncotarget 2017;8:103985-103995.
Go to original source...
Go to PubMed...
- Molino Y. Use of LDL receptor - targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier. FASEB J 2017;31:1807-1827.
Go to original source...
Go to PubMed...
- Kraehling JR. Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells. Nat Commun 2016;7:13516.
Go to original source...
Go to PubMed...
- Hofman A. Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases. Vascul Pharmacol 2017 Oct 19. pii: S1537-1891(17)30171-4.
- Hofman A. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background. Atheroscler Suppl 2017;30:294-302.
Go to original source...
Go to PubMed...
- Balzan S. LOX-1 receptor: A potential link in atherosclerosis and cancer. Life Sci 2018 Feb 17. pii: S0024-3205(18)30080-8.
Go to original source...
Go to PubMed...
- Allahverdian S. Smooth Muscle Cell Fate and Plasticity in Atherosclerosis. Cardiovasc Res. 2018 Jan 27. doi: 10.1093/cvr/cvy022. [Epub ahead of print]
Go to original source...
Go to PubMed...
- Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998;139:205-222.
Go to original source...
- Shirai R. Neopterin Counters Vascular Inflammation and Atherosclerosis. J Am Heart Assoc 2018 Feb 2;7(3). pii: e007359.
Go to original source...
Go to PubMed...
- Wang X. Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL. Oncotarget 2017;8:114442-114456.
Go to original source...
Go to PubMed...
- Guilliams M, van de Laar L. A Hitchhiker's Guide to Myeloid Cell Subsets: Practical Implementation of a Novel Mononuclear Phagocyte Classification System. Front Immunol 2015;6:406.
Go to original source...
Go to PubMed...
- Kim H. The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages. Sci Rep 2017;7:7591.
Go to original source...
Go to PubMed...
- He. S. Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis. Scand J Immunol 2018 Feb 21. doi: 10.1111/sji.12648. [Epub ahead of print]
Go to original source...
Go to PubMed...
- Bras J. miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells. PLoS One 2017;12(11):e0188530.
Go to original source...
Go to PubMed...
- Döring Y. Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies. Circulation 2017;136:388-403.
Go to original source...
Go to PubMed...
- Andreeva ER, Pugach IM, Orekhov AN. Subendothelial smooth muscle cells of himan aorta express macrophage antigen in situ and in vitro. Atherosclerosis. 1997;165:19-27.
Go to original source...
- Hasanov Z. Endosialin Promotes Atherosclerosis Through Phenotypic Remodeling of Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol 2017;37(3):495-505.
Go to original source...
Go to PubMed...
- An D. JNK1 Mediates Lipopolysaccharide-Induced CD14 and SR-AI Expression and Macrophage Foam Cell Formation. Front Physiol 2018;8:1075.
Go to original source...
Go to PubMed...
- Ackers I. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis. Cardiovasc Pathol 2018;34:1-8.
Go to original source...
Go to PubMed...
- Huangfu N. LncRNA MALAT1 regulates oxLDL-induced CD36 expression via activating β-catenin. Biochem Biophys Res Commun 2018;495:2111-2117.
Go to original source...
Go to PubMed...
- Lui Z. Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis. Circ Res 2017;121:1047-1057.
Go to original source...
Go to PubMed...
- Gabunia K. Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC. J Mol Cell Cardiol 2017;105:38-48.
Go to original source...
Go to PubMed...
- Morris G. Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes. Arterioscler Thromb Vasc Biol 2017;37:1050-1057.
Go to original source...
Go to PubMed...
- Geng F. Lipid droplets, potential biomarker and metabolic target in glioblastoma. Intern Med Rev (Wash D C). 2017 May;3(5). doi: 10.18103/imr.v3i5.443.
Go to original source...
Go to PubMed...
- Chinetti-Gbaguidi G. PPARβ in macrophages and atherosclerosis. Biochimie 2017;136:59-64.
Go to original source...
Go to PubMed...
- Se-Jin Jeong. The Role of Macrophage Lipophagy in Reverse Cholesterol Transport. Endocrinol Metab (Seoul) 2017;32:41-46.
Go to original source...
Go to PubMed...
- Zou TB1, Zhu SS1, Luo F, et al. Effects of Astaxanthin on ReverseCholesterol Transport and Atherosclerosis in Mice. Biomed Res Int 2017;2017:4625932.
Go to PubMed...
- Chen X. 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport. Can J Physiol Pharmacol 2018;96:8-17.
Go to original source...
Go to PubMed...
- Pizzini A. The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review. Nutrients. 2017 Oct 6;9(10). pii: E1099.
Go to original source...
Go to PubMed...
- Wen G. Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis. J Am Heart Assoc 2018 Feb 8;7(4). pii: e008187.
Go to original source...
Go to PubMed...
- Adorni M. Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages. Atherosclerosis 2017;256:1-6.
Go to original source...
Go to PubMed...
- Rinne P. Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages. Circulation 2017;136:83-97.
Go to original source...
Go to PubMed...
- Rinne P. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice. Arterioscler Thromb Vasc Biol 2018;38:313-323.
Go to original source...
Go to PubMed...
- Linton F. SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis. Trends Endocrinol Metab 2017;28:461-472.
Go to original source...
Go to PubMed...
- Ren K. MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I. Atherosclerosis 2018;270:57-67.
Go to original source...
Go to PubMed...
- Liy Y. Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor-κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis. Exp Ther Med 2018;15:198-204.
Go to original source...
- Vozenilek AE. Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein- -Induced Proinflammatory Signaling and Atherosclerosis. Arterioscler Thromb Vasc Biol 2018;38:324-334.
Go to original source...
Go to PubMed...
- Fujiwara Y. Acyl Chain Preference in Foam Cell Formation from Mouse Peritoneal Macrophages. Biol Pharm Bull 2018;41:86-91.
Go to original source...
Go to PubMed...
- Gao W. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis. Nat Commun 2018;9:231.
Go to original source...
Go to PubMed...
- Vengrenyuk Y. Cholesterol loading re-programs the miR- -143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol 2015;35:535-546.
Go to original source...
Go to PubMed...
- Langley ER. Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques. J Clin Invest 2017;127:1546-1560.
Go to original source...
Go to PubMed...
- Dautova Y. Calcium phosphate particles stimulate interleukin-1β release from human vascular smooth muscle cells: A role for spleen tyrosine kinase and exosome release. J Mol Cell Cardiol 2018;115:82-93.
Go to original source...
Go to PubMed...
- Verzola D. Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment. Sci Rep 2017;3;7:46362.
Go to original source...
Go to PubMed...
- A novel protective function of 5-methoxytryptophan in vascular injury. Sci Rep 2016;6:25374.
Go to PubMed...
- Lee GL TLR4-Activated MAPK-IL-6 Axis Regulates Vascular Smooth Muscle Cell Function. Int J Mol Sci 2016 Aug 24;17(9).
- Byskov K. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells. Atherosclerosis 2017;265:133-139.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.